Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease Insights From the Oncology Drug Development Experience

Overview of attention for article published in JACC: Basic to Translational Science, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 33 X posts from 28 X users, with an upper bound of 200,156 followers.

RT @NHLBI_Translate: In #JACC article, Dr. Greg Fonarow @gcfmd & colleagues address #barriers in #development and #Implementation and what…

RT @NHLBI_Translate: In #JACC article, Dr. Greg Fonarow @gcfmd & colleagues address #barriers in #development and #Implementation and what…

In #JACC article, Dr. Greg Fonarow @gcfmd & colleagues address #barriers in #development and #Implementation and what we can learn from #oncology to overcome #challenges in developing novel therapies for #cardiovascular diseases. #CVD #Cancer @US_FDA

Study in #JACC shows that, between 2010 and 2017, there were nearly 2.5 times as many #oncology FDA approvals as #CVD approvals. #Cancer #Barriers #Facilitators #Pathways #cardiovascular Seethe proposed bold vision: https://t.co/epQMMwi87B https://t.co/Ra

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 29 additional X posts.